Raymond James Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Raymond James Financial’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.11M	Buy	71,836 +5,098	+8%	+$459K	﹤0.01%	2449
2026 Q1	$5.78M	Buy	66,738 +10,673	+19%	+$934K	﹤0.01%	2472
2025 Q4	$4.76M	Buy	56,065 +1,421	+3%	+$113K	﹤0.01%	2555
2025 Q3	$3.96M	Sell	54,644 -8,920	-14%	-$615K	﹤0.01%	2629
2025 Q2	$4.17M	Buy	63,564 +1,955	+3%	+$127K	﹤0.01%	2497
2025 Q1	$4.35M	Sell	61,609 -6,443	-9%	-$448K	﹤0.01%	2431
2024 Q4	$4.47M	Buy	+68,052	New	+$4.68M	﹤0.01%	2394

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Raymond James Financial's IHE Position: Q2 2026 in Review

Raymond James Financial increased its iShares US Pharmaceuticals ETF (IHE) stake by 7.6% in Q2 2026, buying an estimated $459K and bringing the position to 71,836 shares worth $7.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Raymond James Financial first reported a position in IHE in Q4 2024 and has held it in 7 quarters since. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Raymond James Financial held 71,836 shares of iShares US Pharmaceuticals ETF worth $7.11M as of Q2 2026.
Raymond James Financial bought 5,098 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $459K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2449 holding.
Raymond James Financial first reported a position in iShares US Pharmaceuticals ETF in Q4 2024 and has held it in 7 quarters since.
210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.